Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 51 Show results per page	View Search Criteria \| Help With Results

Last Modified: 2/1/1998


1.		Phase III Randomized, Double-Blind, Placebo-Controlled Study of Low-Dose Gallium Nitrate for Bone Involvement from Breast Cancer (Summary Last Modified 02/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				17 and over				Pharmaceutical / Industry				SP-BC-01 NCI-V96-0813

Last Modified: 2/1/1998


2.		Phase III Randomized, Double-Blind, Placebo-Controlled Study of Low-Dose Gallium Nitrate for Bone Involvement from Multiple Myeloma (Summary Last Modified 02/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				17 and over				Pharmaceutical / Industry				SP-MM-01 NCI-V96-0814

Last Modified: 3/1/1990


3.		Phase III Randomized, Double-Blind Study of Gallium Nitrate vs Disodium Pamidronate (APD) in Patients with Cancer-Related Hypercalcemia (Summary Last Modified 03/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				FRE-IGR-T89-0069 NCI-T89-0069A, T89-0069

Last Modified: 9/1/1987


4.		Phase III Randomized Comparison of Gallium Nitrate vs Etidronate in the Treatment of Cancer-Related Hypercalcemia (Summary Last Modified 09/87)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				MSKCC-8733 NCI-T87-0085C, T87-0085

Last Modified: 5/1/1989


5.		Phase III Randomized Study of Adjuvant Therapy with Gallium Nitrate for Bone Loss in Patients with Multiple Myeloma (Summary Last Modified 05/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				MSKCC-8735 NCI-T87-0089H, T87-0089

Last Modified: 10/1/1995


6.		Phase I/II Study of Continuous-Infusion GAN for Hormone-Refractory Metastatic Prostate Cancer (Summary Last Modified 10/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				over 18				NCI				NCI-94-C-0207A NCI-T94-0095N, T94-0095

Last Modified: 4/1/2001


7.		Phase II Study of Gallium Nitrate in Patients With AIDS-Related Non-Hodgkin's Lymphoma (Summary Last Modified 04/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				RPCI-DS-96-26 UTHSC-9235011358, NCI-T94-0043D, NCT00002578, T94-0043

Last Modified: 8/1/1998


8.		Phase II Study of Vincristine/Ifosfamide/Gallium Nitrate (VIG) for Advanced Nontransitional Cell Carcinoma of the Urothelium (Summary Last Modified 08/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				E-1896 E1896


9.		Phase II Chemotherapy with Gallium Nitrate for Advanced Hodgkin's Disease and non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MSKCC-81107


10.		Phase II Chemotherapy with Gallium Nitrate for Incurable Advanced Soft Tissue and Bone Sarcomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-7911

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute